CVS Group (LON:CVSG) Posts Quarterly Earnings Results

CVS Group (LON:CVSG) issued its quarterly earnings results on Thursday. The company reported GBX 85.60 earnings per share (EPS) for the quarter, Digital Look Earnings reports. CVS Group had a net margin of 2.31% and a return on equity of 5.35%.

Here are the key takeaways from CVS Group’s conference call:

• Revenue rose 5.9% to £712.8 million and adjusted EBITDA increased 5.1% to £141.5 million, with the margin maintained at 19.9% despite inflationary pressures. Adjusted EPS grew 6.9% to 85.6 pence.
• Like-for-like revenue growth was 2.1%, below the company’s 4%–8% target, as weaker U.K. consumer confidence and unusually hot weather reduced routine appointments and delayed procedures. Management said trading has since returned to pre-heatwave levels and expects to perform in line with market expectations.
• CVS completed a refinancing that provides £350 million of committed facilities through May 2030 on improved terms, while leverage remained below its 2.0x threshold at 1.63x. The company is also progressing with a £50 million share buyback expected to finish within the next couple of months.
• Australia remains a key expansion opportunity, contributing about £20 million of EBITDA excluding central costs, with further Australian and U.K. acquisitions signed or completed since year-end. Management expects to invest around £50 million annually in acquisitions while remaining selective on valuation.
• Organic growth initiatives include the Healthy Pet Club Advanced subscription, which had attracted approximately 14,500 clients shortly after launch, alongside digital booking, CRM, AI consultation tools, and improved client communications. Capital expenditure is expected to moderate to about £30 million annually, potentially freeing cash for acquisitions or shareholder returns.

CVS Group Trading Down 6.3%

Shares of CVS Group stock opened at GBX 1,219.70 on Thursday. The stock has a market capitalization of £829.03 million, a P/E ratio of 17.70, a P/E/G ratio of 1.77 and a beta of 1.07. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. The stock’s 50-day simple moving average is GBX 1,289.88 and its 200 day simple moving average is GBX 1,230. CVS Group has a 52-week low of GBX 1,062 and a 52-week high of GBX 1,648.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CVSG shares. Jefferies Financial Group boosted their price objective on shares of CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a “hold” rating in a research report on Friday, July 31st. Berenberg Bank restated a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday. Shore Capital Group reiterated a “hold” rating and issued a GBX 1,400 target price on shares of CVS Group in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 1,700 target price on shares of CVS Group in a research report on Monday, July 27th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, CVS Group currently has an average rating of “Moderate Buy” and an average price target of GBX 1,666.67.

Insider Buying and Selling

In other news, insider Robin Alfonso bought 768 shares of the stock in a transaction on Thursday, August 6th. The shares were bought at an average price of GBX 1,294 per share, with a total value of £9,937.92. Also, insider Joanne Shaw purchased 1,592 shares of the company’s stock in a transaction on Monday, August 10th. The shares were purchased at an average price of GBX 1,287 per share, with a total value of £20,489.04. Insiders purchased a total of 3,860 shares of company stock valued at $4,956,696 over the last three months. Corporate insiders own 1.48% of the company’s stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.